Effects of CBT-I on Impulsivity and Risk Taking in Youths With Insomnia
Effects of Cognitive Behavioural Therapy for Insomnia (CBT-I) on Impulsivity and Risk Taking in Youths With Insomnia: A Randomised Controlled Trial
1 other identifier
interventional
124
1 country
1
Brief Summary
Insomnia is prevalent in adolescents. Impulsive behaviours and excessive risk-taking have been linked to the manifestation of psychopathology in youths. Previous research based on behavioural and neurophysiological measures has found that individuals with insomnia demonstrated impaired inhibitory control, which is associated with detrimental outcomes such as substance abuse and self-harm. Existing evidence has shown some positive effects of cognitive behavioural therapy for insomnia (CBT-I) on insomnia symptoms and daytime functioning in youths. Given the link between insomnia and impulsivity reported in previous research, and sleep as a highly modifiable factor, we are conducting this randomised controlled trial to examine the impact of CBT-I in improving impulsivity and risk-taking in youth with insomnia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 19, 2024
CompletedFirst Submitted
Initial submission to the registry
January 28, 2026
CompletedFirst Posted
Study publicly available on registry
February 10, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
February 10, 2026
February 1, 2026
2.5 years
January 28, 2026
February 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Impulsivity
Change in the degree of impulsivity is the degree will be measured by UPPS-P Impulsive Behavior Scale.
Baseline, one week after the intervention and 6-month after the intervention
Secondary Outcomes (12)
Change in Insomnia Symptoms
Baseline, one week after the intervention and 6-month after the intervention
Change of Sleep Diary Measure - Time in Bed (TIB)
Baseline, one week after the intervention and 6-month after the intervention
Change of Sleep Diary Measure - Total Sleep Time (TST)
Baseline, one week after the intervention and 6-month after the intervention
Change of Sleep Diary Measure - Sleep Onset Latency (SOL)
Baseline, one week after the intervention and 6-month after the intervention
Change of Sleep Diary Measure - Sleep Efficiency (SE)
Baseline, one week after the intervention and 6-month after the intervention
- +7 more secondary outcomes
Study Arms (2)
CBT-I
EXPERIMENTALN = 62
Health-related Psychoeducation control
ACTIVE COMPARATORN = 62
Interventions
CBT-I consists of 6 weekly group sessions (90-min, 5-8 adolescents in each group) delivered in the afternoon/evening after school within a 10-week window. The intervention is structured and based on the well-established CBT elements for treating insomnia. The treatment components aim to address the behavioural, cognitive, and physiological factors perpetuating insomnia whilst considering the sleep and circadian features in adolescents and developmental context with the following key elements: psychoeducation about sleep, circadian rhythm and sleep hygiene, stimulus control, sleep restriction, relaxation training, structured worry time, cognitive restructuring (targeting sleep-related dysfunctional cognitions), and relapse prevention.
The active control group will receive group-based health-related psychoeducation, a format that has been adopted in the previous research, in order to provide the credibility of the intervention to the participants, and to control for the potential effects of attention and nonspecific components, e.g., receiving health-related information, expectations of benefit. It will also consist of 6 weekly sessions which contain education on general well-being, diet, and exercise/activity.
Eligibility Criteria
You may qualify if:
- Chinese aged 12-24 years old
- Written informed consent of participation in the study is given by the participant and his/her parent or guardian (for those aged under 18)
- Willing to comply with the study protocol
- Meeting the DSM-V diagnostic criteria of insomnia disorder and with a score on Insomnia Severity Index (ISI) \>= 9 (suggested cut-off for adolescents)
You may not qualify if:
- A current diagnosis of substance abuse or dependence; a current or past history of manic or hypomanic episode, schizophrenia spectrum disorders, neurodevelopmental disorders, organic mental disorders, or intellectual disabilities
- Having a prominent medical condition known to interfere with sleep continuity and quality (e.g. eczema, gastro-oesophageal reflux disease)
- Having a clinically diagnosed sleep disorder (other than insomnia disorder) that may potentially contribute to a disruption in sleep continuity and quality, such as narcolepsy, sleep-disordered breathing, and restless leg syndrome, as ascertained by the Structured Interview for Sleep Patterns and Disorders (DISP), a validated structured diagnostic interview to assess major sleep disorders according to the International Classification of Sleep Disorder (ICSD) criteria
- Concurrent, regular use of medications(s) known to affect sleep continuity and quality including both western medications (e.g. hypnotics, steroids) and over-the-counter OTC medications (e.g. melatonin, Traditional Chinese Medicine, TCM)
- In the opinion of the research clinician, having a clinically significant suicidality (presence of suicidal ideation with a plan or an attempt)
- Currently receiving any psychological treatment for insomnia
- With hearing or speech deficit
- Night shift worker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The University of Hong Konglead
- Chinese University of Hong Kongcollaborator
- King's College Londoncollaborator
Study Sites (1)
Sleep Research Clinic and Laboratory, Department of Psychology, The University of Hong Kong
Hong Kong, Hong Kong
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 28, 2026
First Posted
February 10, 2026
Study Start
June 19, 2024
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
February 10, 2026
Record last verified: 2026-02